KEYVIBE-001
Phase 1 Completed
474 enrolled 39 charts
MK-4830-001
Phase 1 Completed
470 enrolled
Carboplatin and Bevacizumab for Recurrent Ependymoma
Phase 2 Completed
35 enrolled 17 charts
AtTEnd
Phase 3 Completed
549 enrolled
EURTAC
Phase 3 Completed
174 enrolled 20 charts
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
Phase 1 Completed
9 enrolled
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Phase 1 Completed
829 enrolled 100 charts
IVY
Phase 1 Completed
353 enrolled
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]
Completed
851 enrolled
IO-001
Phase 1 Completed
119 enrolled
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]
Completed
304 enrolled
CANFOUR
Phase 1/2 Completed
167 enrolled
AVANA
Phase 3 Completed
731 enrolled 19 charts
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Phase 2/3 Completed
361 enrolled 16 charts
Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours
Phase 1/2 Completed
19 enrolled 12 charts
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer
Phase 3 Completed
634 enrolled
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
240 enrolled
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Phase 2 Completed
97 enrolled
DENALI
Phase 2 Completed
82 enrolled 10 charts
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Phase 1 Completed
16 enrolled 14 charts
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
Phase 1 Completed
141 enrolled
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
Phase 1 Completed
24 enrolled
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
Phase 1 Completed
8 enrolled 26 charts
MK-2206-003
Phase 1 Completed
77 enrolled 24 charts
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Phase 1 Completed
65 enrolled 32 charts
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma
Phase 2 Completed
90 enrolled 13 charts
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
Phase 2 Completed
64 enrolled 20 charts
Dose-finding Study in Platinum-Resistant Ovarian Cancer
Phase 1/2 Completed
59 enrolled 18 charts
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
Phase 1 Completed
9 enrolled 7 charts
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel
Phase 1 Completed
169 enrolled
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)
Phase 2 Completed
128 enrolled
Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors
Phase 1 Completed
34 enrolled 18 charts
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase 2 Completed
103 enrolled 13 charts
A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen
Phase 1 Completed
36 enrolled
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Phase 1 Completed
43 enrolled 21 charts
A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors
Phase 1 Completed
136 enrolled
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
Phase 2 Completed
62 enrolled 9 charts
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Phase 1 Completed
83 enrolled 42 charts
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
Phase 2 Completed
51 enrolled 7 charts
Combination Paclitaxel, Carboplatin and Temozolomide
Phase 1 Completed
15 enrolled
Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL
Phase 2 Completed
20 enrolled 6 charts
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
FALCON
Phase 2 Completed
63 enrolled 18 charts
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Phase 1 Completed
59 enrolled
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Phase 1 Completed
16 enrolled
RAD001 Plus Carboplatin in Breast Cancer Patients
Phase 2 Completed
25 enrolled 9 charts
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
Phase 2 Completed
60 enrolled 10 charts
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
63 enrolled 15 charts
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
Phase 1 Completed
58 enrolled
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Phase 2 Completed
49 enrolled